BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15520002)

  • 1. Novel mechanism of interaction of p85 subunit of phosphatidylinositol 3-kinase and ErbB3 receptor-derived phosphotyrosyl peptides.
    Suenaga A; Takada N; Hatakeyama M; Ichikawa M; Yu X; Tomii K; Okimoto N; Futatsugi N; Narumi T; Shirouzu M; Yokoyama S; Konagaya A; Taiji M
    J Biol Chem; 2005 Jan; 280(2):1321-6. PubMed ID: 15520002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
    Weber T; Schaffhausen B; Liu Y; Günther UL
    Biochemistry; 2000 Dec; 39(51):15860-9. PubMed ID: 11123912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase.
    Moon KD; Post CB; Durden DL; Zhou Q; De P; Harrison ML; Geahlen RL
    J Biol Chem; 2005 Jan; 280(2):1543-51. PubMed ID: 15536084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.
    Hellyer NJ; Cheng K; Koland JG
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):757-63. PubMed ID: 9677338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a phage display library to identify basic residues in A-Raf required to mediate binding to the Src homology 2 domains of the p85 subunit of phosphatidylinositol 3'-kinase.
    King TR; Fang Y; Mahon ES; Anderson DH
    J Biol Chem; 2000 Nov; 275(46):36450-6. PubMed ID: 10967104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
    Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
    Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics, free energy, and SPR analyses of the interactions between the SH2 domain of Grb2 and ErbB phosphotyrosyl peptides.
    Suenaga A; Hatakeyama M; Ichikawa M; Yu X; Futatsugi N; Narumi T; Fukui K; Terada T; Taiji M; Shirouzu M; Yokoyama S; Konagaya A
    Biochemistry; 2003 May; 42(18):5195-200. PubMed ID: 12731860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
    Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
    J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.
    Fu Z; Aronoff-Spencer E; Backer JM; Gerfen GJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3275-80. PubMed ID: 12629217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides.
    Morelock MM; Ingraham RH; Betageri R; Jakes S
    J Med Chem; 1995 Apr; 38(8):1309-18. PubMed ID: 7537332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphopeptide binding to the N-terminal SH2 domain of the p85 alpha subunit of PI 3'-kinase: a heteronuclear NMR study.
    Hensmann M; Booker GW; Panayotou G; Boyd J; Linacre J; Waterfield M; Campbell ID
    Protein Sci; 1994 Jul; 3(7):1020-30. PubMed ID: 7522724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of cyclic hexapeptides designed as constrained ligands for the SH2 domain of the p85 subunit of phosphatidylinositol-3-OH kinase.
    Barchi JJ; Nomizu M; Otaka A; Roller PP; Burke TR
    Biopolymers; 1996 Feb; 38(2):191-208. PubMed ID: 8589253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.